Connor, Clark & Lunn Investment Management (CC&L)’s Genomic Health, Inc. GHDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,150
| Closed | -$396K | – | 1097 |
|
|
2018
Q4 | $396K | Buy |
+6,150
| New | +$396K | ﹤0.01% | 750 |
|
|
2016
Q3 | – | Sell |
-12,195
| Closed | -$316K | – | 949 |
|
|
2016
Q2 | $316K | Sell |
12,195
-26,905
| -69% | -$697K | ﹤0.01% | 664 |
|
|
2016
Q1 | $969K | Sell |
39,100
-21,000
| -35% | -$520K | 0.01% | 465 |
|
|
2015
Q4 | $2.12M | Buy |
60,100
+13,600
| +29% | +$479K | 0.02% | 332 |
|
|
2015
Q3 | $984K | Buy |
+46,500
| New | +$984K | 0.01% | 404 |
|